Sera Prognostics Inc Cash Flow Conversion Efficiency
Sera Prognostics Inc cash flow conversion efficiency. Based on the latest financial reports, Sera Prognostics Inc (SERA) has a cash flow conversion efficiency ratio of -0.106x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.31 Million) by net assets ($59.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sera Prognostics Inc (2019–2025)
Cash flow conversion efficiency of Sera Prognostics Inc from 2019 to 2025. This chart illustrates how Sera Prognostics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Sera Prognostics Inc for real-time trading data and today's change.
Sera Prognostics Inc Cash Flow Conversion Ratio Explained
Sera Prognostics Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sera Prognostics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sera Prognostics Inc ranked by their cash flow conversion efficiency. Also see market value of Sera Prognostics Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brightek Optoelectronic Co Ltd
TW:5244
|
-0.020x |
|
Kalray SA
PA:ALKAL
|
0.230x |
|
Thac Ba Hydropower JSC
VN:TBC
|
0.057x |
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
-0.018x |
|
Aviv Arlon Ltd
TA:AVLN
|
-0.017x |
|
Railcare Group AB (publ)
ST:RAIL
|
0.232x |
|
IT City Public Company Limited
BK:IT
|
0.008x |
|
Onano Industrial Corp
TW:6405
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Sera Prognostics Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Sera Prognostics Inc from 2019 to 2025. Review Sera Prognostics Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $75.41 Million | $-25.62 Million | -0.340x | -14.48% |
| 2024-12-31 | $47.80 Million | $-14.19 Million | -0.297x | +23.41% |
| 2023-12-31 | $70.16 Million | $-27.19 Million | -0.388x | -10.79% |
| 2022-12-31 | $98.94 Million | $-34.61 Million | -0.350x | -53.21% |
| 2021-12-31 | $138.56 Million | $-31.64 Million | -0.228x | +96.02% |
| 2020-12-31 | $2.94 Million | $-16.87 Million | -5.737x | -225.29% |
| 2019-12-31 | $10.96 Million | $-19.32 Million | -1.764x | -- |
About Sera Prognostics Inc
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of… Read more